Wang Bin, Guo Hanfei, Yu Hongquan, Chen Yong, Xu Haiyang, Zhao Gang
Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China.
Cancer Center, The First Hospital of Jilin University, Changchun, China.
Front Oncol. 2021 Mar 24;11:642547. doi: 10.3389/fonc.2021.642547. eCollection 2021.
Early growth response factor 1 (EGR1) is a transcription factor that is mainly involved in the processes of tissue injury, immune responses, and fibrosis. Recent studies have shown that EGR1 is closely related to the initiation and progression of cancer and may participate in tumor cell proliferation, invasion, and metastasis and in tumor angiogenesis. Nonetheless, the specific mechanism whereby EGR1 modulates these processes remains to be elucidated. This review article summarizes possible mechanisms of action of EGR1 in tumorigenesis and tumor progression and may serve as a reference for clinical efficacy predictions and for the discovery of new therapeutic targets.
早期生长反应因子1(EGR1)是一种转录因子,主要参与组织损伤、免疫反应和纤维化过程。最近的研究表明,EGR1与癌症的发生和发展密切相关,可能参与肿瘤细胞的增殖、侵袭和转移以及肿瘤血管生成。然而,EGR1调节这些过程的具体机制仍有待阐明。这篇综述文章总结了EGR1在肿瘤发生和肿瘤进展中的可能作用机制,可为临床疗效预测和新治疗靶点的发现提供参考。